Pour médecins et pharmaciens
1 Module - 1 Orateur
12 mois à partir du 07/12/2020
Asthma is characterized by chronic inflammation of the airway.
Type 2 inflammation is present in 50%* of patients with severe asthma.
We will discuss the significant patient burden of disease and need for treatment options that address the actions of key inflammatory cytokines including IL-4, IL-5 and IL-13, which play a central role in contributing to the Type 2 inflammatory response.
*Peters MC et al. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol. 2014;133(2):388–394. n=108/205
Pneumology : n° 20021706 (1,5 CP)
Pr Bart Lambrecht
- New Insights in Type II Inflammation in Severe Asthma
- Q & A and conclusion